GE HealthCare Technologies Inc. $GEHC Shares Acquired by Empowered Funds LLC

Empowered Funds LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 774.0% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 163,381 shares of the company’s stock after acquiring an additional 144,688 shares during the period. Empowered Funds LLC’s holdings in GE HealthCare Technologies were worth $11,629,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares in the last quarter. Auto Owners Insurance Co grew its position in GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after purchasing an additional 33,629,559 shares during the last quarter. Dodge & Cox increased its stake in GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after purchasing an additional 3,693,918 shares in the last quarter. Capital Research Global Investors increased its stake in GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after purchasing an additional 389,796 shares in the last quarter. Finally, State Street Corp raised its holdings in shares of GE HealthCare Technologies by 2.0% in the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after buying an additional 401,932 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Buying and Selling

In related news, Director Watkin Phoebe L. Yang purchased 1,000 shares of the business’s stock in a transaction on Friday, May 8th. The shares were bought at an average cost of $63.01 per share, with a total value of $63,010.00. Following the transaction, the director owned 13,702 shares of the company’s stock, valued at approximately $863,363.02. This trade represents a 7.87% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Rodney F. Hochman acquired 1,618 shares of GE HealthCare Technologies stock in a transaction on Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, with a total value of $100,364.54. Following the purchase, the director directly owned 1,618 shares in the company, valued at approximately $100,364.54. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased a total of 15,928 shares of company stock valued at $1,005,761 over the last quarter. 0.36% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have recently commented on GEHC shares. Oppenheimer reiterated an “outperform” rating and set a $85.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Barclays cut their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 30th. Hovde Group began coverage on GE HealthCare Technologies in a research note on Friday, July 17th. They issued a “market perform” rating and a $14.00 target price for the company. Piper Sandler reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research report on Wednesday. Finally, HSBC dropped their price target on GE HealthCare Technologies from $100.00 to $90.00 in a research note on Thursday, April 30th. Ten analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Hold” and a consensus target price of $76.59.

More GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare reported adjusted earnings of $1.13 per share, exceeding the $1.04 analyst consensus, while revenue reached approximately $5.29 billion versus expectations of $5.26 billion. Revenue rose about 5.8% year over year, helped by increased orders and healthy demand. GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds
• Positive Sentiment: Orders grew approximately 11% organically, book-to-bill reached a post-spin-off record near 1.15, and backlog climbed to a record $23.9 billion. The metrics provide stronger future revenue visibility and suggest hospitals are resuming capital investments in imaging and diagnostic infrastructure. GEHC Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Pharmaceutical Diagnostics delivered particularly strong growth, while imaging demand remained healthy. Management also said it is reviewing strategic alternatives for the underperforming Patient Care Solutions business, potentially allowing GE HealthCare to improve margins by restructuring or divesting the unit. GE HealthCare reports second quarter 2026 financial results
• Positive Sentiment: BTIG Research raised its GEHC price target from $75 to $79 and assigned a “Buy” rating, reinforcing the positive earnings reaction and suggesting additional upside based on the firm’s estimates. BTIG raises GE HealthCare price target
• Neutral Sentiment: Unusually high call-option activity showed traders purchasing roughly 8,956 contracts, about 45% above average. This reflects bullish speculative interest but does not directly change GE HealthCare’s fundamentals.
• Negative Sentiment: The earnings beat benefited from a tariff refund and a lower tax rate, which may not recur. Adjusted EBIT margins also contracted by roughly 40 basis points to about 14.2%, with Patient Care Solutions reporting a sharp organic revenue decline and negative EBIT.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $71.90 on Thursday. The company has a 50 day simple moving average of $63.83 and a two-hundred day simple moving average of $70.69. The stock has a market cap of $32.71 billion, a price-to-earnings ratio of 17.20, a PEG ratio of 1.74 and a beta of 0.72. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same quarter in the prior year, the business earned $1.06 earnings per share. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is presently 3.35%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.